Cargando…

NF-κB is weakly activated in the NOD mouse model of type 1 diabetes

Type 1 diabetes is an autoimmune disease characterised by selective destruction of pancreatic beta cells by the immune system. The transcription factor nuclear factor-kappa B (NF-κB) regulates innate and adaptive immune responses. Using gene targeting and in vitro analysis of pancreatic islets and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Irvin, Allison E., Jhala, Gaurang, Zhao, Yuxing, Blackwell, Timothy S., Krishnamurthy, Balasubramanian, Thomas, Helen E., Kay, Thomas W. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844878/ https://www.ncbi.nlm.nih.gov/pubmed/29523846 http://dx.doi.org/10.1038/s41598-018-22738-3

Ejemplares similares

Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice
por: Jhala, Gaurang, et al.
Publicado: (2021)

Complete Diabetes Protection Despite Delayed Thymic Tolerance in NOD8.3 TCR Transgenic Mice Due to Antigen-Induced Extrathymic Deletion of T Cells
por: Krishnamurthy, Balasubramanian, et al.
Publicado: (2012)

The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice
por: Ge, Tingting, et al.
Publicado: (2020)

Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitor
por: Ge, Tingting, et al.
Publicado: (2022)

The NOD Mouse Beyond Autoimmune Diabetes
por: Aubin, Anne-Marie, et al.
Publicado: (2022)

Effect of Sulforaphane on NOD2 via NF-κB: implications for Crohn’s disease
por: Folkard, Danielle L, et al.
Publicado: (2015)

IFNγ-Induced MHC Class II Expression on Islet Endothelial Cells Is an Early Marker of Insulitis but Is Not Required for Diabetogenic CD4(+) T Cell Migration
por: Scott, Nicholas A., et al.
Publicado: (2018)

NOD2-C2 - a novel NOD2 isoform activating NF-κB in a muramyl dipeptide-independent manner
por: Kramer, Marcel, et al.
Publicado: (2010)

Involvement of ayu NOD2 in NF-κB and MAPK signaling pathways: Insights into functional conservation of NOD2 in antibacterial innate immunity
por: Ren, Yi, et al.
Publicado: (2018)

Monitoring immunomodulation strategies in type 1 diabetes
por: Krishnamurthy, Balasubramanian, et al.
Publicado: (2023)

IL-21 regulates SOCS1 expression in autoreactive CD8(+) T cells but is not required for acquisition of CTL activity in the islets of non-obese diabetic mice
por: Sutherland, Andrew P. R., et al.
Publicado: (2019)

Recognition of Lipopolysaccharide and Activation of NF-κB by Cytosolic Sensor NOD1 in Teleost Fish
por: Bi, Dekun, et al.
Publicado: (2018)

Differences in the Expression of TLR-2, NOD2, and NF-κB in Placenta Between Twins
por: Szylberg, Łukasz, et al.
Publicado: (2018)

RIP2 filament formation is required for NOD2 dependent NF-κB signalling
por: Pellegrini, Erika, et al.
Publicado: (2018)

Eugenol modulates the NOD1-NF-κB signaling pathway via targeting NF-κB protein in triple-negative breast cancer cells
por: Shi, Xiaoyu, et al.
Publicado: (2023)

Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse
Publicado: (1987)

Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ
por: Barham, Whitney, et al.
Publicado: (2015)

GEF-H1 Mediated Control of NOD1 Dependent NF-κB Activation by Shigella Effectors
por: Fukazawa, Atsuko, et al.
Publicado: (2008)

IKKα Contributes to Canonical NF-κB Activation Downstream of Nod1-Mediated Peptidoglycan Recognition
por: Kim, Man Lyang, et al.
Publicado: (2010)

Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse
por: Tahvili, Sahar, et al.
Publicado: (2018)

The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse
por: Borg, Danielle J., et al.
Publicado: (2017)

Granzyme B Is Dispensable in the Development of Diabetes in Non-Obese Diabetic Mice
por: Mollah, Zia U., et al.
Publicado: (2012)

ZnT8-Reactive T Cells Are Weakly Pathogenic in NOD Mice but Can Participate in Diabetes Under Inflammatory Conditions
por: Nayak, Deepak K., et al.
Publicado: (2014)

Analyses of Transcriptomics upon IL-1β-Stimulated Mouse Chondrocytes and the Protective Effect of Catalpol through the NOD2/NF-κB/MAPK Signaling Pathway
por: Pang, Yong, et al.
Publicado: (2023)

Defining the Transcriptional and Cellular Landscape of Type 1 Diabetes in the NOD Mouse
por: Carrero, Javier A., et al.
Publicado: (2013)

Correction: Defining the Transcriptional and Cellular Landscape of Type 1 Diabetes in the NOD Mouse
por: Carrero, Javier A., et al.
Publicado: (2014)

Expression of TLR-2, TLR-4, NOD2 and pNF-κB in a Neonatal Rat Model of Necrotizing Enterocolitis
por: Le Mandat Schultz, Aurelie, et al.
Publicado: (2007)

The Inositol Phosphatase SHIP-1 Inhibits NOD2-Induced NF-κB Activation by Disturbing the Interaction of XIAP with RIP2
por: Condé, Claude, et al.
Publicado: (2012)

Replacing murine insulin 1 with human insulin protects NOD mice from diabetes
por: Elso, Colleen M., et al.
Publicado: (2019)

Altered Metabolic Signature in Pre-Diabetic NOD Mice
por: Madsen, Rasmus, et al.
Publicado: (2012)

Influence of Caloric Restriction on Constitutive Expression of NF-κB in an Experimental Mouse Astrocytoma
por: Mulrooney, Tiernan J., et al.
Publicado: (2011)

Genome-wide end-sequenced BAC resources for the NOD/MrkTac(☆) and NOD/ShiLtJ(☆☆) mouse genomes
por: Steward, Charles A., et al.
Publicado: (2010)

Sulindac activates NF-κB signaling in colon cancer cells
por: Mladenova, Dessislava, et al.
Publicado: (2013)

Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice
por: Ramakrishnan, Parameswaran, et al.
Publicado: (2016)

Infection of human intestinal epithelial cells by invasive bacteria activates NF-κB and increases ICAM-1 expression through NOD1
por: Shin, Woon Geon, et al.
Publicado: (2018)

Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice
Publicado: (1988)

Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model
por: Malek Abrahimians, Elin, et al.
Publicado: (2016)

Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB Activation
por: Khan, Pasha M., et al.
Publicado: (2011)

Sleeping Beauty Transposon Mutagenesis as a Tool for Gene Discovery in the NOD Mouse Model of Type 1 Diabetes
por: Elso, Colleen M., et al.
Publicado: (2015)

Prevention of Cyclophosphamide-induced Accelerated Diabetes in the NOD Mouse by Nicotinamide or a Soy Protein-based Infant Formula
por: Reddy, S., et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_qhmtljddavjudaq7i9ni0dfsih